raloxifene hydrochloride has been researched along with Chronic Illness in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhondzadeh, S; Fatehi, F; Hashempoor, S; Kashani, L; Khodaei-Ardakani, MR; Kianimehr, G; Nazari, A; Rezaei, F | 1 |
| Amano, N; Sugiyama, E; Sugiyama, N; Yokoyama, S | 1 |
| Hamano, T | 1 |
| Braga, S; Cannata-Andía, JB; Carrillo-López, N; Fernández-Coto, T; López-Hernández, F; Lopez-Novoa, JM; Naves-Díaz, M; Rodríguez-Rodríguez, A | 1 |
| Ishimura, E; Okuno, S | 1 |
| Karp, BI; Nieman, LK; Silberstein, SD; Sinaii, N; Stratton, P | 1 |
| Hsu, AL; Nieman, LK; Segars, J; Sinaii, N; Stratton, P | 1 |
| Oberender, P; Zerth, J | 1 |
| Koziol, D; Nieman, LK; Segars, J; Sinaii, N; Stratton, P; Wesley, R; Winkel, C; Zimmer, C | 1 |
2 review(s) available for raloxifene hydrochloride and Chronic Illness
| Article | Year |
|---|---|
[Effects of SERMs on bone health. The potential of SERM in the care of chronic kidney disease-mineral bone and disorders].
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Evidence-Based Medicine; Fractures, Spontaneous; Humans; Kidney Diseases; Osteoporosis; Parathyroid Hormone; Practice Guidelines as Topic; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Vitamin D | 2010 |
[Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Diphosphonates; Fractures, Spontaneous; Humans; Kidney Diseases; Minerals; Raloxifene Hydrochloride; Reference Standards | 2010 |
4 trial(s) available for raloxifene hydrochloride and Chronic Illness
| Article | Year |
|---|---|
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Raloxifene Hydrochloride; Risperidone; Schizophrenia; Selective Estrogen Receptor Modulators; Treatment Outcome | 2014 |
Migraine in women with chronic pelvic pain with and without endometriosis.
Topics: Adolescent; Adult; Chronic Disease; Combined Modality Therapy; Endometriosis; Estrogen Antagonists; Female; Humans; Laparoscopy; Middle Aged; Migraine Disorders; Pelvic Pain; Placebos; Prevalence; Prospective Studies; Quality of Life; Raloxifene Hydrochloride; Young Adult | 2011 |
Relating pelvic pain location to surgical findings of endometriosis.
Topics: Adolescent; Adult; Biopsy; Bone Density Conservation Agents; Chronic Disease; Endometriosis; Female; Humans; Laparoscopy; Middle Aged; Pelvic Pain; Raloxifene Hydrochloride; Young Adult | 2011 |
Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial.
Topics: Adult; Chronic Disease; Endometriosis; Female; Humans; Laparoscopy; Pelvic Pain; Quality of Life; Raloxifene Hydrochloride; Recurrence; Selective Estrogen Receptor Modulators; Treatment Outcome | 2008 |
3 other study(ies) available for raloxifene hydrochloride and Chronic Illness
| Article | Year |
|---|---|
Five female cases of prolonged depression in chronic anorexia nervosa treated with selective estrogen receptor modulator raloxifene-augmented therapy.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents; Chronic Disease; Depression; Female; Humans; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome | 2008 |
Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.
Topics: Animals; Atrophy; Bone Density Conservation Agents; Calcitriol; Calcium; Cholesterol; Chronic Disease; Estradiol; Estrogens; Female; Hyperplasia; Kidney Diseases; Mammary Glands, Animal; Organ Size; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tibia; Uterus | 2010 |
The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy.
Topics: Bone Density Conservation Agents; Calcium, Dietary; Chronic Disease; Cost-Benefit Analysis; Dietary Supplements; Diphosphonates; Drug Combinations; Drug Packaging; Female; Germany; Humans; Male; Models, Econometric; Osteoporosis; Patient Compliance; Physician-Patient Relations; Raloxifene Hydrochloride | 2008 |